The value of carcinoembryonic antigen in differentiating sclerosing epithelial hamartoma from syringoma.

Abstract	We examined 4 cases of sclerosing epithelial hamartoma for the presence of carcinoembryonic antigen (CEA) by the unlabelled antibody peroxidase-antiperoxidase method but could not detect CEA in these lesions. Because syringomas contain CEA, the detection of this antigen is a useful marker for differentiating sclerosing epithelial hamartomas from syringomas.
Authors	D Landau-Price, R L Barnhill, A P Kowalcyzk, N S Penneys, J Ziegels-Weissman
Journal	Journal of cutaneous pathology (J Cutan Pathol) Vol. 12 Issue 1 Pg. 8-12 (Feb 1985) ISSN: 0303-6987 [Print] United States
PMID	3882791 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Carcinoembryonic Antigen
Topics	Adenoma (analysis, diagnosis, pathology) Carcinoembryonic Antigen (analysis) Diagnosis, Differential Hamartoma (analysis, diagnosis, pathology) Humans Immunoenzyme Techniques Sclerosis Skin Neoplasms (analysis, diagnosis, pathology) Sweat Gland Neoplasms (analysis, diagnosis, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!